Literature DB >> 11196114

Prolactin, a marker for cerebral dopamine deficiency in patients suffering from phenylketonuria (PKU)?

J Denecke1, W Schlegel, G H Koch, R Feldmann, E Harms, J Weglage.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11196114     DOI： 10.1023/a:1026725122142

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN： 0141-8955            Impact factor:   4.982


× No keyword cloud information.
  6 in total

1.  Prolactin responses to phenylalanine and tyrosine in phenylketonuria.

Authors:  H E Carlson; D B Hyman; C Bauman; R Koch
Journal:  Metabolism       Date:  1992-05       Impact factor: 8.694

2.  The effects of high phenylalanine concentrations on serotonin and catecholamine metabolism in the human brain.

Authors:  C M McKean
Journal:  Brain Res       Date:  1972-12-12       Impact factor: 3.252

3.  Elevated serum prolactin concentrations in phenylketonuric patients on a 'loose diet'.

Authors:  K H Schulpis; E Papakonstantinou; H Michelakakis; T Theodoridis; U Papandreou; A Constantopoulos
Journal:  Clin Endocrinol (Oxf)       Date:  1998-01       Impact factor: 3.478

4.  Serotonin and dopamine synthesis in phenylketonuria.

Authors:  H C Curtius; A Niederwieser; M Viscontini; W Leimbacher; H Wegmann; B Blehova; F Rey; J Schaub; H Schmidt
Journal:  Adv Exp Med Biol       Date:  1981       Impact factor: 2.622

5.  Blood-brain barrier phenylalanine transport and individual vulnerability in phenylketonuria.

Authors:  H E Möller; J Weglage; D Wiedermann; K Ullrich
Journal:  J Cereb Blood Flow Metab       Date:  1998-11       Impact factor: 6.200

6.  Dietary problems of phenylketonuria: effect on CNS transmitters and their possible role in behaviour and neuropsychological function.

Authors:  F Güttler; H Lou
Journal:  J Inherit Metab Dis       Date:  1986       Impact factor: 4.982
  6 in total
  1 in total

1.  Serum prolactin as a biomarker for the study of intracerebral dopamine effect in adult patients with phenylketonuria: a cross-sectional monocentric study.

Authors:  Eszter Juhász; Erika Kiss; Erika Simonova; Attila Patócs; Peter Reismann
Journal:  Eur J Med Res       Date:  2016-05-11       Impact factor: 2.175
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.